Activity value 87International Buyer&Supplier,Last transaction date:
2026-03-21Address: belgica,rixensart,rue de i┤insititut, 89 b-1330 rixen
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for glaxosmithkline biologicals s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 50 transactions, with a transaction quantity of 1237312.75 and a transaction weight of 39555.2.
YearTransactionsQuantityWeight
202563116300485.04354696.26
2026501237312.7539555.2
Bill of lading data
<
1/15
>
Trade date
2026/03/21
B/L No.
cec2026la030482
Suppliers
glaxosmithkline biologicals s.a.
Buyers
ministrio de salud publica
Product description
INFLUENZA ANTISERUM SAMPLES FOC NCV ONLY FOR TESTING PURPOSE AT CDTLINFLUENZA ANTISERUM SAMPLES FOC NCV ONLY FOR TESTING PURPO
Expand
Product description
SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE ADSORBED I P LIST 2 SR NO 80 PAC SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VA
Expand
Product description
SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE ADSORBED I P LIST 2 SR NO 80 PAC SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VA
Expand
Product description
STREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 500UL EACH FOC NCV STRAINS FOR ANALYSIS USESTREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 500UL E
Expand
Product description
STREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 1 0UL EACH FOC NCV STRAINS FOR ANALYSIS USESTREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 1 0UL E
Expand
Trade date
2026/02/11
B/L No.
cec2026la030264
Suppliers
glaxosmithkline biologicals s.a.
Buyers
ministrio de salud publica
5gsk vx marietta
united statesbuyer,they trade on 2025-03-29
2834.35%
>
+View All
Products
Total 281
ProductsTransactionsPerDetail
gh 25224.88%>
cod 19018.76%>
3m 15615.4%>
cf 14814.61%>
vial 12912.73%>
+View All
Hscode rank
Total 288
HSCode NameTransactionsPerDetail
HS 3002419018918.66%>
HS 300241900012011.85%>
HS 30024119605.92%>
HS 38229090414.05%>
HS 30021290353.46%>
+View All
Trading Area
Total 25
AreaTransactionsPerDetail
united states117818.1%>
colombia109016.75%>
russia95014.6%>
ukraine72611.15%>
vietnam5207.99%>
+View All
Port statistics
Total 47
Port NameTransactionsPerDetail
antwerp113417.42%>
bruxelles brussel2423.72%>
bruxelles1201.84%>
brussels1111.71%>
brussel bruxelles1001.54%>
+View All
glaxosmithkline biologicals s.a. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as gh,cod,3m.
According to the 52wmb.com global trade database, as of 2026-03-21, the company has completed 6602 international trades,
with its main trading regions covering united states,colombia,russia etc.
The core products include HS30024190,HS3002419000,HS30024119 etc,
often transported via antwerp,port bruxelles brussel, port bruxelles etc,
and its main trading partners are glaxosmithkline colombia s.a.,ооо вортэкс,gsk biologicals north america.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on glaxosmithkline biologicals s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.